A failed trial for a heart drug casts shadow over rivals developing similar therapies
Image: MarketWatch
ad slot · in-content video 16:9
Coverage
Coverage
- The full data from the closely watched clinical trial showed that the drug had no cardiovascular benefit even though it reduced Lp(a) levels.